Abbott Laboratories (ABT) Monthly Backtest Results
Backtest Summary
This table summarises how profitable it would have been to have bought this stock at each monthly entry signal. The compound annual growth rate (CAGR) shows the profitability of the trade on an annualised basis.
| Entry Date | Exit Date | Profit or Loss | CAGR |
|---|---|---|---|
| 01 October 2024 | 03 November 2025 | 8.68% | 7.96% |
| 02 January 2024 | 01 May 2024 | -2.81% | -8.3% |
| 01 August 2023 | 01 September 2023 | -6.78% | -56.23% |
| 01 February 2023 | 01 March 2023 | -9.46% | -72.64% |
| 01 June 2020 | 01 March 2022 | 28.24% | 15.32% |
| 01 March 2017 | 02 March 2020 | 85.27% | 22.77% |
| 01 September 2016 | 01 November 2016 | -6.45% | -33.35% |
| 01 December 2015 | 01 February 2016 | -17.18% | -67.03% |
| Total Return | 79.52% | ||
The monthly data for Abbott Laboratories (exchange: XNYS symbol: ABT) was last updated 27 Dec 2025 05:22. Data for this stock is available from 01 Sep 2015 - 26 Dec 2025.
